Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Cohance Lifesciences Ltd.
NSE: COHANCE
|
BSE: 543064
|
ISIN: INE03QK01018
|
Industry: Pharmaceuticals
52 week low
|
Expensive Underperformer
421.5500
-4.40
(
-1.03
%)
NSE
Jan 19, 2026
11:19 AM
New 52W Low today
Volume:
214.0K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Cohance Lifesciences Ltd.
09 Aug 2022
52 week low
421.55
-1.03%
Suven Pharmaceuticals
Hold:
Cohance Lifesciences Ltd.
by
ICICI Direct
Target: 530
Target
ICICI Direct
Promoters have decreased holdings from 66.41% to 57.49% in Sep 2025 qtr
More from Cohance Lifesciences Ltd.
Recommended
Market trades lower, ICICI Bank's Q3FY26 net profit declines 4% YoY
Trendlyne Marketwatch |
19 Jan 2026, 11:03AM
Five Interesting Stocks Today - January 16, 2026
The Baseline |
16 Jan 2026
Nifty 50 outlook: Hopes rise for 2026 after a volatile year
The Baseline |
15 Jan 2026